temozolomide has been researched along with Infections in 2 studies
Infections: Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The temozolomide is a promising orally cytotoxic agent used in malignant glioma." | 8.83 | The safety of the temozolomide in patients with malignant glioma. ( Dario, A; Tomei, G, 2006) |
| "The authors investigated the safety of 75 mg/m2 temozolomide for 21 days every 28 days in glioma patients." | 7.73 | Is protracted low-dose temozolomide feasible in glioma patients? ( Blatt, V; Brandes, AA; Cavallo, G; Ermani, M; Franceschi, E; Gardiman, M; Ghimenton, C; Pasetto, L; Scopece, L; Tosoni, A, 2006) |
| "The temozolomide is a promising orally cytotoxic agent used in malignant glioma." | 4.83 | The safety of the temozolomide in patients with malignant glioma. ( Dario, A; Tomei, G, 2006) |
| "The authors investigated the safety of 75 mg/m2 temozolomide for 21 days every 28 days in glioma patients." | 3.73 | Is protracted low-dose temozolomide feasible in glioma patients? ( Blatt, V; Brandes, AA; Cavallo, G; Ermani, M; Franceschi, E; Gardiman, M; Ghimenton, C; Pasetto, L; Scopece, L; Tosoni, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dario, A | 1 |
| Tomei, G | 1 |
| Tosoni, A | 1 |
| Cavallo, G | 1 |
| Ermani, M | 1 |
| Scopece, L | 1 |
| Franceschi, E | 1 |
| Ghimenton, C | 1 |
| Gardiman, M | 1 |
| Pasetto, L | 1 |
| Blatt, V | 1 |
| Brandes, AA | 1 |
1 review available for temozolomide and Infections
| Article | Year |
|---|---|
The safety of the temozolomide in patients with malignant glioma.
Topics: Adult; Antineoplastic Agents, Alkylating; Child; Clinical Trials as Topic; Dacarbazine; Drug Interac | 2006 |
1 other study available for temozolomide and Infections
| Article | Year |
|---|---|
Is protracted low-dose temozolomide feasible in glioma patients?
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Dose- | 2006 |